Peery AF, Crockett SD, Murphy CC et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156:254-272.e11.

Article  PubMed  Google Scholar 

Lu J, Xu A, Wang J et al. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. BMC Health Serv Res. 2013;13:37.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen MH, Burak Ozbay A, Liou I et al. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B. J Hepatol. 2019;70:24–32.

Article  PubMed  Google Scholar 

HCUP-US NIS overview. Accessed March 16, 2022, at https://www.hcup-us.ahrq.gov/nisoverview.jsp

Khera R, Angraal S, Couch T et al. Adherence to methodological standards in research using the national inpatient sample. JAMA. 2017;318:2011–2018.

Article  PubMed  PubMed Central  Google Scholar 

NIS Related Reports. Accessed March 13, 2022, at https://www.hcup-us.ahrq.gov/db/nation/nis/nisrelatedreports.jsp

Cost H, Project U et al. NIS Description of Data Elements. Rockville: Agency for Healthcare Research and Quality; 2008.

Google Scholar 

NIS Database Documentation. Accessed March 16, 2022, at https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp

Huang LS, Chen J. Analysis of variance, coefficient of determination and F-test for local polynomial regression. AOS. 2008;36:2085–2109.

Google Scholar 

Kokla M, Virtanen J, Kolehmainen M, Paananen J, Hanhineva K. Random forest-based imputation outperforms other methods for imputing LC-MS metabolomics data: a comparative study. BMC Bioinformatics. 2019;20:492.

Article  PubMed  PubMed Central  Google Scholar 

Vyas AK, Singh AK. Chronic hepatitis B patients: a relation of age and comorbidities. Saudi J Gastroenterol. 2019;25:141.

Article  PubMed  PubMed Central  Google Scholar 

Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635–639.

Article  CAS  PubMed  Google Scholar 

Kang CK, Brennan PN, Dillon JF. How to effectively monitor aging patients with chronic hepatitis B: a review. Clin Interv Aging. 2022;17:1811–1820.

Article  PubMed  PubMed Central  Google Scholar 

Fabrizi F, Donato FM, Messa P. Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis. Ann Hepatol. 2017;16:21–47.

Article  PubMed  Google Scholar 

Merle P, Trépo C, Zoulim F. Current management strategies for hepatitis B in the elderly. Drugs Aging. 2001;18:725–735.

Article  CAS  PubMed  Google Scholar 

De Santis A, Maggi D, Lubrano LF. Safety and efficacy of directly-acting antiviral therapy for chronic hepatitis C virus in elderly people. Aging Med (Milton). 2021;4:304–316.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed MM, Shaarawy HO, Anwar I, Sarhan MD. Barriers to completing therapy for hepatitis C with direct-acting antivirals: a real-life experience from a single treatment center in Egypt. J Prim Care Commu Health. 2021;12:11.

Google Scholar 

Ghidei L, Simone MJ, Salow MJ et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013;30:809–819.

Article  PubMed  Google Scholar 

Kim M, Paik J, Golabi P, Jeffers T, Mishra A, Younossi ZM. Resource utilization and outcomes of medicare recipients with chronic hepatitis B in the United States. J Clin Gastroenterol. 2019;53:e341–e347.

Article  CAS  PubMed  Google Scholar 

Nguyen MH, Lim JK, Burak Ozbay A et al. Advancing age and comorbidity in a US insured population-based cohort of patients With chronic hepatitis B. Hepatology. 2019;69:959–973.

Article  PubMed  Google Scholar 

Dai D, Sharma A, Phillips AL, Lobo C. Patterns of comorbidity and multimorbidity among patients with multiple sclerosis in a large US commercially insured and medicare advantage population. J Health Econ Outcomes Res. 2022;9:125–133.

Article  PubMed  PubMed Central  Google Scholar 

Beschloss A, Mueller J, Caldwell JME et al. Comparison of medical comorbidities in Medicare patients treated by orthopaedic surgeons and neurosurgeons throughout the USA. Bone Jt Open. 2020;1:257–260.

Article  PubMed  PubMed Central  Google Scholar 

Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases. BMC Med. 2017;15:216.

Article  PubMed  PubMed Central  Google Scholar 

Lochner KA, Cox CS. Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010. Prev Chronic Dis. 2013;10:E61.

Article  PubMed  PubMed Central  Google Scholar 

Stepanova M, Al Qahtani S, Mishra A, Younossi I, Venkatesan C, Younossi ZM. Outcomes of liver transplantation by insurance types in the United States. Am J Manag Care. 2020;26:e121–e126.

Article  PubMed  Google Scholar 

Bryce CL, Angus DC, Arnold RM et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092–2101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang AE, Terrault NA, Fong TL, Zhou K. Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system. Hepatol Commun. 2023. https://doi.org/10.1097/HC9.0000000000000081.

Article  PubMed  PubMed Central  Google Scholar 

Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–1599.

Article  PubMed  Google Scholar 

US Preventive Services Task Force, Krist AH, Davidson KW et al. Screening for hepatitis B virus infection in adolescents and adults: US preventive services task force recommendation statement. JAMA. 2020;324:2415–2422.

Article  Google Scholar 

Roberts H, Ly KN, Yin S, Hughes E, Teshale E, Jiles R. Prevalence of HBV infection, vaccine-induced immunity, and susceptibility among at-risk populations: US households, 2013–2018. Hepatology. 2021;74:2353–2365.

Article  CAS  PubMed  Google Scholar 

2020 Newly Reported Chronic Hepatitis B by Demographic. Accessed February 20, 2023, at https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-b/table-2.6.htm

Ye Q, Kam LY, Yeo YH et al. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US. J Hepatol. 2022;76:63–74.

Article  CAS  PubMed  Google Scholar 

Lee S, Yoon H, Chen L, Juon HS. Culturally appropriate photonovel development and process evaluation for hepatitis B prevention in Chinese, Korean, and Vietnamese American communities. Health Educ Behav. 2013;40:694–703.

Article  PubMed  Google Scholar 

Hyun S, Ko O, Kim S, Ventura WR. Sociocultural barriers to hepatitis B health literacy in an immigrant population: a focus group study in Korean Americans. BMC Public Health. 2021;21:404.

Article  PubMed  PubMed Central  Google Scholar 

Smith-Palmer J, Cerri K, Sbarigia U et al. Impact of Stigma on People Living with Chronic Hepatitis B. Patient Relat Outcome Meas. 2020;11:95–107.

Article  PubMed  PubMed Central  Google Scholar 

Zarębska-Michaluk D, Flisiak R, Flisiak-Jackiewicz M. Management of hepatitis B and hepatitis C coinfection: an expert review. Expert Rev Anti Infect Ther. 2020;18:1033–1044.

Article  PubMed  Google Scholar 

Mao X, Cheung KS, Peng C et al. Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis. Hepatology. 2023;77:1735–1745.

Article  PubMed  Google Scholar 

Wong YJ, Nguyen VH, Yang HI et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023. https://doi.org/10.3350/cmh.2023.0004.

Article  PubMed  PubMed Central  Google Scholar